Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2022 — = -38.33% × —
Dec 31, 2021 -88.29% = -25.59% × 3.45
Dec 31, 2020 -112.27% = -23.85% × 4.71
Dec 31, 2019 — = -41.99% × —
Dec 31, 2018 -409.84% = -50.33% × 8.14

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Three-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2022 — = -411.21% × 0.09 × —
Dec 31, 2021 -88.29% = -305.72% × 0.08 × 3.45
Dec 31, 2020 -112.27% = -228.00% × 0.10 × 4.71
Dec 31, 2019 — = -452.93% × 0.09 × —
Dec 31, 2018 -409.84% = -337.41% × 0.15 × 8.14

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Five-Component Disaggregation of ROE

Cytokinetics Inc., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2022 — = — × — × -390.68% × 0.09 × —
Dec 31, 2021 -88.29% = — × — × -282.38% × 0.08 × 3.45
Dec 31, 2020 -112.27% = — × — × -199.41% × 0.10 × 4.71
Dec 31, 2019 — = — × — × -428.28% × 0.09 × —
Dec 31, 2018 -409.84% = — × — × -325.36% × 0.15 × 8.14

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Two-Component Disaggregation of ROA

Cytokinetics Inc., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2022 -38.33% = -411.21% × 0.09
Dec 31, 2021 -25.59% = -305.72% × 0.08
Dec 31, 2020 -23.85% = -228.00% × 0.10
Dec 31, 2019 -41.99% = -452.93% × 0.09
Dec 31, 2018 -50.33% = -337.41% × 0.15

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Four-Component Disaggregation of ROA

Cytokinetics Inc., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2022 -38.33% = — × — × -390.68% × 0.09
Dec 31, 2021 -25.59% = — × — × -282.38% × 0.08
Dec 31, 2020 -23.85% = — × — × -199.41% × 0.10
Dec 31, 2019 -41.99% = — × — × -428.28% × 0.09
Dec 31, 2018 -50.33% = — × — × -325.36% × 0.15

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Disaggregation of Net Profit Margin

Cytokinetics Inc., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2022 -411.21% = — × — × -390.68%
Dec 31, 2021 -305.72% = — × — × -282.38%
Dec 31, 2020 -228.00% = — × — × -199.41%
Dec 31, 2019 -452.93% = — × — × -428.28%
Dec 31, 2018 -337.41% = — × — × -325.36%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).